|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2008-7-11
|
|
pubmed:abstractText |
Early virological response (VR) to enfuvirtide-based salvage regimens at week 12 has been described as a predictor of long-term therapeutic success. The relationship between enfuvirtide plasma exposure and VR has not yet been investigated in the clinical setting. Our aim was to investigate the role of enfuvirtide plasma exposure as a determinant of early VR in the clinical setting.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1460-2091
|
|
pubmed:author |
pubmed-author:BonoraStefanoS,
pubmed-author:CalcagnoAndreaA,
pubmed-author:CastagnaAntonellaA,
pubmed-author:D'AvolioAntonioA,
pubmed-author:Di PerriGiovanniG,
pubmed-author:HassonHamidH,
pubmed-author:LazzarinAdrianoA,
pubmed-author:MaruccoDiego AguilarDA,
pubmed-author:SciandraMauroM,
pubmed-author:TrentiniLauraL,
pubmed-author:de RequenaDaniel GonzalezDG
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
62
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
384-7
|
|
pubmed:meshHeading |
pubmed-meshheading:18487231-Female,
pubmed-meshheading:18487231-HIV Envelope Protein gp41,
pubmed-meshheading:18487231-HIV Fusion Inhibitors,
pubmed-meshheading:18487231-HIV Infections,
pubmed-meshheading:18487231-Humans,
pubmed-meshheading:18487231-Inhibitory Concentration 50,
pubmed-meshheading:18487231-Male,
pubmed-meshheading:18487231-Middle Aged,
pubmed-meshheading:18487231-Models, Statistical,
pubmed-meshheading:18487231-Peptide Fragments,
pubmed-meshheading:18487231-Plasma,
pubmed-meshheading:18487231-Prospective Studies,
pubmed-meshheading:18487231-Salvage Therapy,
pubmed-meshheading:18487231-Treatment Outcome,
pubmed-meshheading:18487231-Viral Load
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Pharmacokinetic and pharmacodynamic determinants of early virological response to enfuvirtide-based regimens in HIV-positive patients.
|
|
pubmed:affiliation |
Department of Infectious Diseases, University of Turin, Turin, Italy. danifarre@hotmail.com
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
